![Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/661cfda4-cb2f-4b37-a52b-fc1ad3d7427e/gr1_lrg.jpg)
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine
![Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram](https://www.researchgate.net/publication/337365816/figure/fig2/AS:963539879608324@1606737217071/Age-standardized-incidence-and-mortality-rates-of-Hodgkins-lymphoma-a-and.png)
Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram
![Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers - ScienceDirect Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121000926-grabsf1.jpg)
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers - ScienceDirect
![Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ec1e9a10-2856-4c0c-9159-7d938fdcf2a6/cam43298-fig-0001-m.jpg)
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library
![Estimating Long-Term Survival for Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy: A Comparison of Standard and Mixture Cure Models - Biology of Blood Estimating Long-Term Survival for Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy: A Comparison of Standard and Mixture Cure Models - Biology of Blood](https://www.astctjournal.org/cms/attachment/2119122619/2089439753/ybbmt54915-fig-0007.jpg)
Estimating Long-Term Survival for Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy: A Comparison of Standard and Mixture Cure Models - Biology of Blood
![JCM | Free Full-Text | A Decade of Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: Does the Outcome Improve? JCM | Free Full-Text | A Decade of Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: Does the Outcome Improve?](https://www.mdpi.com/jcm/jcm-10-05114/article_deploy/html/images/jcm-10-05114-g001.png)
JCM | Free Full-Text | A Decade of Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: Does the Outcome Improve?
![Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-020-00340-z/MediaObjects/41408_2020_340_Fig2_HTML.png)
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal
![Overall survival rates of 200 patients with non-Hodgkin lymphoma by the... | Download Scientific Diagram Overall survival rates of 200 patients with non-Hodgkin lymphoma by the... | Download Scientific Diagram](https://www.researchgate.net/publication/12237891/figure/fig1/AS:282385057894410@1444337252816/Overall-survival-rates-of-200-patients-with-non-Hodgkin-lymphoma-by-the-pretreatment.png)
Overall survival rates of 200 patients with non-Hodgkin lymphoma by the... | Download Scientific Diagram
![Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis](https://www.frontiersin.org/files/Articles/588314/fonc-10-588314-HTML/image_m/fonc-10-588314-g001.jpg)
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project | Haematologica
![Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram](https://www.researchgate.net/publication/5882500/figure/fig2/AS:264602101481473@1440097465361/Overall-survival-according-to-the-Follicular-Lymphoma-International-Prognostic-Index-19.png)
Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram
![Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy](https://www.mdpi.com/diagnostics/diagnostics-07-00026/article_deploy/html/images/diagnostics-07-00026-g001.png)
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
![Kaplan-Meier estimates for aggressive non-Hodgkin lymphoma (NHL) that... | Download Scientific Diagram Kaplan-Meier estimates for aggressive non-Hodgkin lymphoma (NHL) that... | Download Scientific Diagram](https://www.researchgate.net/publication/323138363/figure/fig3/AS:627086771367957@1526520545911/Kaplan-Meier-estimates-for-aggressive-non-Hodgkin-lymphoma-NHL-that-achieved-complete.png)